Planning a Summer vacation? Where to go? How about going to one of those large events with tens…
On Jul. 23, 2021, RELIEF THERAPEUTICS announced that the parent company of its collaboration partner, NRx Pharmaceuticals, reported…
On Jul. 23, 2021, Moderna announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
On Jul. 23, 2021, Pfizer and BioNTech announced that the U.S. government had purchased an additional 200 million…
On Jul. 21, 2021, Humanigen announced its development and commercialization partners for South Korea and the Philippines, Telcon…
On Jul. 22, 2021, Moderna announced a new supply agreement with Taiwan for 20 million doses of Moderna’s…
On Jul. 21, 2021, Sorrento Therapeutics announced that COVID-19 patients had been dosed in its Phase 2 efficacy…
On Jul. 21, 2021, Pfizer and BioNTech announced the signing of a letter of intent with The Biovac…
On Jul. 20, 2021, Roche announced that Japanﾒs Ministry of Health, Labour and Welfare (MHLW) had approved Ronapreveﾙ(casirivimab…
On Jul. 20, 2021, Moderna announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and…
On Jul. 20, 2021, Regeneron announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) had approved Regeneron’s…
On Jul. 16, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had granted…
On Jul. 15, 2021, Corvus Pharmaceuticals announced that it had discontinued its Phase 3 study of mupadolimab for…
On Jul. 15, 2021, iBio announced that preclinical studies of IBIO-202, its subunit vaccine candidate that targets the…
On Jul. 14, 2021, Hologic announced that it had obtained a CE Mark for the use of saliva…
On Jul. 13, 2021, RELIEF THERAPEUTICS reported that its collaboration partner, NRx Pharmaceuticals, and Quantum Leap Healthcare Collaborativeﾙ…
On Jul. 13, 2021, the Food and Drug Administration (FDA) revisions to the vaccine recipient and vaccination provider…
On Jul. 12, 2021, Moderna announced a supply agreement with the government of Argentina for 20 million doses…
On Jul. 12, 2021, BioNTech announced that Fosun Industrial Co. had reached advance procurement agreements for the mRNA-based…
On Jul. 12, 2021, Gavi, the Vaccine Alliance, announced that it had signed advance purchase agreements with Sinopharm…
On Jul. 9, 2021, Humanigen announced its submission for Marketing Authorization for lenzilumab in COVID-19, begun in Jun….
On Jul. 8, 2021, the National Institutes of Health (NIH) announced that a new study authored by scientists…
On Jul. 7, 2021, Rice University announced a study to develop an inhalable COVID-19 vaccine. The project led…
On Jul. 6, 2021, the World Health Organization announced updated patient care guidelines to include interleukin-6 receptor blockers,…
On Jul. 6, 2021, Dynavax Technologies and Biological E announced the execution of a commercial supply agreement of…
On Jul. 2, 2021, the Food and Drug Administration (FDA) authorized the use, under the emergency use authorization…
On Jul. 1, 2021, Moderna confirmed that following the European Medicines Agency’s (EMA) Committee for Human Medicines (CHMP)…
On Jul. 1, 2021, HDT Bio announced the U.S. Food and Drug Administration had reviewed the companyﾒs Investigational…
On Jun. 30, 2021, Atea Pharmaceuticals announced positive interim results from the global Phase 2 study evaluating AT-527…
On Jun. 30, 2021, the National Institutes of Health announced a highly anticipated study that compared rapid antigen…